Abstract
Thrombin, a highly specific protease of blood coagulation, has two exosites that modulate its specificity. We designed two sets of synthetic substrate FRET peptides with 25- or 11- amino acids (aa) each, based on the PAR 1 sequence, to characterize the effect of exosite 1 engagement on substrate catalysis and preference. The 25-aa set encompassed a sequence binding to exosite 1, and structural modeling showed that binding to thrombin did not differ significantly from that of PAR 1 peptide. Modification at the P3´position of the 25 or 11-aa peptides resulted in small effect on kinetic parameters. Ionic strength higher than physiologic depressed thrombin action on the 25-aa peptides. Addition of ligands of the exosite 1 negatively modulated the catalysis of 25-aa substrates. In conclusion, we succeeded to mimic and study in real time, using these synthetic peptides, the influence of ligand binding to exosite 1 on thrombin activity.
Keywords: Enzyme activity, exosite 1, fluorogenic peptides, PAR 1 and thrombin.
Protein & Peptide Letters
Title:Investigation of Thrombin Activity with PAR 1-based Fluorogenic Peptides
Volume: 20 Issue: 10
Author(s): Saulo Martins Vieira, Flavia Garcia dos Reis, Reinaldo Geraldo, Denis Luis da Silva Dutra, Luiz Juliano, Maria Aparecida Julianod, Julio Alberto Mignaco and Russolina Benedeta Zingali
Affiliation:
Keywords: Enzyme activity, exosite 1, fluorogenic peptides, PAR 1 and thrombin.
Abstract: Thrombin, a highly specific protease of blood coagulation, has two exosites that modulate its specificity. We designed two sets of synthetic substrate FRET peptides with 25- or 11- amino acids (aa) each, based on the PAR 1 sequence, to characterize the effect of exosite 1 engagement on substrate catalysis and preference. The 25-aa set encompassed a sequence binding to exosite 1, and structural modeling showed that binding to thrombin did not differ significantly from that of PAR 1 peptide. Modification at the P3´position of the 25 or 11-aa peptides resulted in small effect on kinetic parameters. Ionic strength higher than physiologic depressed thrombin action on the 25-aa peptides. Addition of ligands of the exosite 1 negatively modulated the catalysis of 25-aa substrates. In conclusion, we succeeded to mimic and study in real time, using these synthetic peptides, the influence of ligand binding to exosite 1 on thrombin activity.
Export Options
About this article
Cite this article as:
Vieira Martins Saulo, Reis Garcia dos Flavia, Geraldo Reinaldo, Dutra Luis da Silva Denis, Juliano Luiz, Julianod Aparecida Maria, Mignaco Alberto Julio and Zingali Benedeta Russolina, Investigation of Thrombin Activity with PAR 1-based Fluorogenic Peptides, Protein & Peptide Letters 2013; 20 (10) . https://dx.doi.org/10.2174/09298665113209990001
DOI https://dx.doi.org/10.2174/09298665113209990001 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
Call for Papers in Thematic Issues
Therapeutic Proteins and Peptides of Plant Origin
Plants are still the major repository of biologically active substances. In the last two decades, however, natural peptides and proteins of plant origin have gained increasing attention due to their pharmacological activities over a variety of human illnesses, including those mediated by infections and parasitosis and those involving different cellular ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aquaporin and Vascular Diseases
Current Neuropharmacology Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Advances in Clinical Study of Curcumin
Current Pharmaceutical Design The Negative Influence of Socio-Technical Developments on Eating Habits and Health
Current Nutrition & Food Science Large-Scale Purification of Human BACE Expressed in Mammalian Cells and Removal of the Prosegment with HIV-1 Protease to Improve Crystal Diffraction
Protein & Peptide Letters Synaptic Activity-Regulated Wnt Signaling in Synaptic Plasticity, Glial Function and Chronic Pain
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Induced Cell-Based Transplantation to Therapeutically Target Spinal Cord Disorders)
Current Stem Cell Research & Therapy The Resting-State Functional Connectivity of the Default Mode Networks in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome
CNS & Neurological Disorders - Drug Targets Monoclonal Antibodies in Allergy; Updated Applications and Promising Trials
Recent Patents on Inflammation & Allergy Drug Discovery Fluorescent Agonists and Antagonists for Vasopressin/Oxytocin G Protein-Coupled Receptors: Usefulness in Ligand Screening Assays and Receptor Studies
Mini-Reviews in Medicinal Chemistry Chronopharmacology and Antimicrobial Therapeutics
Current Clinical Pharmacology Liquiritigenin Decreases Selective Molecular and Behavioral Effects of Cocaine in Rodents
Current Neuropharmacology Mephedrone Impact on Matrix Metalloproteinases Activity - Do they Influence the Memory Processes?
Current Molecular Pharmacology Stroke Induced Immunodepression Syndrome: From Bench to Bedside
Current Molecular Medicine Statins and Protein Prenylation in Cancer Cell Biology and Therapy
Anti-Cancer Agents in Medicinal Chemistry Commentary (Research Highlights)
CNS & Neurological Disorders - Drug Targets Outcome Measures for Clinical Trials in Interstitial Lung Diseases
Current Respiratory Medicine Reviews Neurotransplantation Therapy and Cerebellar Reserve
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Glia: A New Cellular Target in the Treatment of Major Depression)
Current Drug Targets